Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells: A possible mechanism for its effect in heart failure

Circulation

Volumn 96, Issue 5, 1997, Pages 1386-1389

  Matsumori, Akira ^a   Ono, Koh ^b   Nishio, Ryosuke ^b   Nose, Yoshisuke ^b   Sasayama, Shigetake ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

Amiodarone; Heart failure; Immune system; Interleukins

Indexed keywords

AMIODARONE; CYTOKINE; DISOPYRAMIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIDOCAINE; QUINIDINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOMODULATION; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0030869622     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.5.1386     Document Type: Article

References (32)

1. Cleland JG, Dargie HJ, Findlay IN, Wilson JT. Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure. Br Heart J. 1987;57:436-445.
2. Hamer AW, Arkles LB, Johns JA. Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial. J Am Coll Cardiol. 1989;14:1768-1774.
3. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med. 1995;333:77-82.
4. Massie BM, Fisher SG, Deedwania PC, Singh BN, Fletcher RD, Singh SN, for the CHF-STAT Investigators. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. Circulation. 1996;93:2128-2134.
5. Pratt CM, Eaton CM, Francis M, Woolbert S, Mahmarian J, Roberts R, Young JB. The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio. Am Heart J. 1989;118:433-440.
6. Stevenson WG. Mechanisms and management of arrhythmias in heart failure. Curr Opin Cardiol. 1995;10:274-281.
7. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects: a review with special reference to torsade de pointes tachycardia. Ann Intern Med. 1994;121:529-535.
8. Chatterjee K. Amiodarone in chronic heart failure. J Am Coll Cardiol. 1989;14:1755-1756.
9. Shioi T, Matsumori A, Matsui S, Sasayama S. Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line. Life Sci. 1994;54: PL11-PL16.
10. Matsumori A, Shioi T, Yamada T, Matsui S, Sasayama S. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation. 1994;89:955-958.
11. Matsumori A, Ono K, Sato Y, Shioi T, Nose Y, Sasayama S. Differential modulation of cytokine production by drugs: implications for therapy in heart failure. J Mol Cell Cardiol. 1996;28: 2491-2499.
12. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure (GESICA). Lancet. 1994;344:493-498.
13. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest. 1994;105: 897-904.
14. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561-566.
15. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
16. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
17. Hocking DC, Phillips PG, Ferro TJ, Johnson A. Mechanisms of pulmonary edema induced by tumor necrosis factor-α. Circ Res. 1990;67:68-77.
18. Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet. 1990;335:294-295. Letter.
19. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest. 1993; 92:2303-2312.
20. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor-β. J Clin Invest. 1995;95:677-685.
21. Woodley SL, McMillan M, Shelby J, Lynch DH, Roberts LK, Ensley RD, Barry WH. Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes. Circulation. 1991;83: 1410-1418.
22. Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci U S A. 1995;92:4862-4866.
23. Katz AM. The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart. Ann Intern Med. 1994;121: 363-371.
24. Matsumori A, Kawai C. An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation. 1982;66:355-360.
25. Matsumori A, Kawai C. An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice. Circulation. 1982;65:1230-1235.
26. Yamada T, Matsumori A, Sasayama S. Therapeutic effect of anti-tumor necrosis factor-a antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation. 1994;89:846-851.
27. Shioi T, Matsumori A, Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation. 1996;94:2930-2937.
28. Gallin EK. Ion channels in leukocytes. Physiol Rev. 1991;71: 775-811.
29. Lewis RS, Cahalan MD. Ion channels and signal transduction in lymphocytes. Ann Rev Physiol. 1990;52:415-430.
30. Lin CS, Boltz RC, Blake JT, Nguyen M, Talente A, Fischer PA, Springer MS, Sigal NH, Slaughter RS, Garcia ML, Kaczorowski GJ, Koo GC. Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T-lymphocyte activation. J Exp Med. 1993;177:637-645.
31. Iijima T, Taira N. Membrane current changes responsible for the positive inotropic effect of OPC 8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heart. J Pharmacol Exp Ther. 1987;240:657-662.
32. Sato R, Koumi S, Singer DH, Hisatome I, Jia H, Eager S, Wasserstrom JA. Amiodarone blocks the inward rectifier potassium channel in isolated guinea pig ventricular cells. J Pharmacol Exp Ther. 1994;269:1213-1219.